跳至主要内容
临床试验/JPRN-jRCTs062230014
JPRN-jRCTs062230014招募中2 期

Safety and efficacy of EUS-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Pilot study

Matsumoto Kazuyuki0 个研究点目标入组 5 人开始时间: 2023年5月12日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • 1. Age more than 18 years old
  • 2. Patient who have been fully informed consent.
  • 3. Pathologically confirmed PNEN with grade by EUS-FNA (WHO 2017 classification)
  • 4. Tumor size 15 mm or less on CE-CT
  • 5. non-functionnal PNEN or insulinom

排除标准

  • 1. Allergy for contrast medium
  • 2. Placement of a cardiac pacemaker
  • 3. Within 2 mm of the distance between tumor and main pancreatic duct on radiographic images
  • 4. Suspect of lymph node metastasis or distant metastasis on CE-CT.
  • 5. Less than 50% of PT or less than 1.5 of INR
  • 6. Less than 50,000/ L of PLT
  • 7. Less than 30 mL/min of eGFR
  • 8. Administeration of more than 2 antithrombotic
  • 9. Not less than 2 of performance status
  • 10. Being pregnant or possibly pregnant
  • 11. Less than 5 years of estimated prognosis
  • 12. Patients judged as inappropriate candidate by
  • the chief medical examiner

研究者

发起方
Matsumoto Kazuyuki

相似试验